4.4 Article

Alphavirus Restriction by IFITM Proteins

Journal

TRAFFIC
Volume 17, Issue 9, Pages 997-1013

Publisher

WILEY-BLACKWELL
DOI: 10.1111/tra.12416

Keywords

alphavirus; IFITM; interferon inducible transmembrane protein; restriction factor; Semliki Forest virus; SFV; virus entry; virus-host interaction

Categories

Funding

  1. UK Medical Research Council [MC_U122665002]
  2. Wellcome Trust [098051]
  3. Medical Research Council [G1000413]
  4. Biotechnology and Biological Sciences Research Council [BB/L00397X/2] Funding Source: researchfish
  5. Medical Research Council [MC_U122665002, 1223252, MC_UU_12018/1] Funding Source: researchfish
  6. BBSRC [BB/L00397X/2] Funding Source: UKRI
  7. MRC [MC_UU_12018/1, MC_U122665002] Funding Source: UKRI

Ask authors/readers for more resources

Interferon inducible transmembrane proteins (IFITMs) are broad-spectrum antiviral factors. In cell culture the entry of many enveloped viruses, including orthomyxo-, flavi-, and filoviruses, is inhibited by IFITMs, though the mechanism(s) involved remain unclear and may vary between viruses. We demonstrate that Sindbis and Semliki Forest virus (SFV), which both use endocytosis and acid-induced membrane fusion in early endosomes to infect cells, are restricted by the early endosomal IFITM3. The late endosomal IFITM2 is less restrictive and the plasma membrane IFITM1 does not inhibit normal infection by either virus. IFITM3 inhibits release of the SFV capsid into the cytosol, without inhibiting binding, internalization, trafficking to endosomes or low pH-induced conformational changes in the envelope glycoprotein. Infection by SFV fusion at the cell surface was inhibited by IFITM1, but was equally inhibited by IFITM3. Furthermore, an IFITM3 mutant (Y20A) that is localized to the plasma membrane inhibited infection by cell surface fusion more potently than IFITM1. Together, these results indicate that IFITMs, in particular IFITM3, can restrict alphavirus infection by inhibiting viral fusion with cellular membranes. That IFITM3 can restrict SFV infection by fusion at the cell surface equivalently to IFITM1 suggests that IFITM3 has greater antiviral potency against SFV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available